Shandong Pharmaceutical Glass Co Ltd
SSE:600529
EV/GP
Enterprise Value to Gross Profit
Market Cap | EV/GP | ||||
---|---|---|---|---|---|
CN |
S
|
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
|
18.9B CNY | 13.4 | |
CH |
Alcon AG
SIX:ALC
|
39.8B CHF | 9.1 | ||
JP |
Hoya Corp
TSE:7741
|
6.8T JPY | 9.8 | ||
DK |
Coloplast A/S
CSE:COLO B
|
188.7B DKK | 12.2 | ||
US |
Align Technology Inc
NASDAQ:ALGN
|
21.1B USD | 7.4 | ||
US |
Cooper Companies Inc
NYSE:COO
|
19.5B USD | 9.1 | ||
KR |
H
|
HLB Inc
KOSDAQ:028300
|
12.3T KRW | -13 662.7 | |
CN |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
58.5B CNY | 18.3 | ||
UK |
ConvaTec Group PLC
LSE:CTEC
|
5.4B GBP | 37 | ||
US |
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
5.9B USD | 3.5 | ||
US |
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.5B USD | 6.1 |
EV/GP Forward Multiples
Forward EV/GP multiple is a version of the EV/GP ratio that uses forecasted gross profit for the EV/GP calculation. 1-Year, 2-Years, and 3-Years forwards use gross profit forecasts for 1, 2, and 3 years ahead, respectively.